- Home
- ORGO vs CWCO Comparison
ORGO vs CWCO Comparison
Compare ORGO & CWCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- CWCO
- Stock Information
- Founded
- ORGO 1985
- CWCO 1973
- Country
- ORGO United States
- CWCO Cayman Islands
- Employees
- ORGO N/A
- CWCO N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- CWCO Water Supply
- Sector
- ORGO Health Care
- CWCO Utilities
- Exchange
- ORGO Nasdaq
- CWCO Nasdaq
- Market Cap
- ORGO 539.1M
- CWCO 554.4M
- IPO Year
- ORGO N/A
- CWCO N/A
- Fundamental
- Price
- ORGO $5.14
- CWCO $34.04
- Analyst Decision
- ORGO Buy
- CWCO Strong Buy
- Analyst Count
- ORGO 3
- CWCO 1
- Target Price
- ORGO $8.00
- CWCO $40.00
- AVG Volume (30 Days)
- ORGO 3.1M
- CWCO 97.4K
- Earning Date
- ORGO 11-06-2025
- CWCO 11-10-2025
- Dividend Yield
- ORGO N/A
- CWCO 1.63%
- EPS Growth
- ORGO N/A
- CWCO N/A
- EPS
- ORGO N/A
- CWCO 1.05
- Revenue
- ORGO $465,218,000.00
- CWCO $130,832,698.00
- Revenue This Year
- ORGO $2.51
- CWCO $1.99
- Revenue Next Year
- ORGO $25.45
- CWCO $57.75
- P/E Ratio
- ORGO N/A
- CWCO $31.87
- Revenue Growth
- ORGO 2.24
- CWCO N/A
- 52 Week Low
- ORGO $2.61
- CWCO $22.69
- 52 Week High
- ORGO $7.08
- CWCO $38.36
- Technical
- Relative Strength Index (RSI)
- ORGO 50.25
- CWCO 45.28
- Support Level
- ORGO $5.09
- CWCO $32.96
- Resistance Level
- ORGO $5.83
- CWCO $34.76
- Average True Range (ATR)
- ORGO 0.50
- CWCO 1.20
- MACD
- ORGO -0.08
- CWCO -0.12
- Stochastic Oscillator
- ORGO 3.02
- CWCO 19.07
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About CWCO Consolidated Water Co. Ltd.
Consolidated Water Co Ltd is a water utility company. It develops and operates seawater desalination plants and water distribution systems. The company's business segments are; The retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Island, The bulk segment supplies potable water to government utilities in Grand Cayman and The Bahamas under long-term contracts, The services segment designs, constructs and sells water infrastructure and provides management and operating services to third parties. The manufacturing segment manufactures and services a wide range of custom and specialized water-related products applicable to commercial, municipal, and industrial water production, supply, and treatment, and the corporate segment.